Oragenics Inc. Stock
Oragenics Inc. Stock
Certainly not a favorite of our community, Oragenics Inc. currently has 33 Sell predictions and 1 Buy predictions.
On the other hand, the target price of 8 € is above the current price of 7.6 € for Oragenics Inc., so the potential is actually 5.32%.
Pros and Cons of Oragenics Inc. in the next few years
Pros
?
B****
?
S********** s********
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Oragenics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Oragenics Inc. | - | - | - | - | - | - | - |
| Solasia Pharma KK | 5.930% | 6.716% | -12.270% | -50.347% | -46.642% | -86.250% | - |
| Larimar Therapeutics Inc. | 8.660% | - | - | - | - | - | - |
| Vaxart Inc. | -5.240% | 9.535% | -41.053% | -15.301% | 30.334% | -89.873% | - |
Comments
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for OGEN provided by MarketBeat
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for OGEN provided by MarketBeat
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for OGEN provided by MarketBeat